Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Synaptic Imaging and Brain Network Activity Following Ketamine in Treatment Resistant Depression

NCT05870501 is registered in ClinicalTrials.gov with King's College London as lead sponsor.

NCT NCT05870501
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05870501 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Synaptic Imaging and Brain Network Activity Following Ketamine in Treatment Resistant Depression
Lead sponsor
King's College London
Phase
Not applicable
Overall status
Completed
Start date
October 20, 2021
Completion date
September 13, 2023
Enrollment
56 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, bipolar disorder, bipolar disorder i, bipolar disorder ii, depressive disorder, depressive disorder, major, depressive disorder, treatment-resistant, mood disorders